Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fibrinogen gamma and thrombolysis response in acute ischemic stroke
NL-OMON34726Not yet recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jan 2010
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label, single-arm trial of tissue-plasminogen activator in ischemic stroke, sponsored by Amsterdam University Medical Center. Primary endpoint: Neurological improvement at 24 hours and discharge. Planned start Jan 2010; status: not yet recruiting.
02
Drugs
tissue-plasminogen activator
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NL-OMON34726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON34726.